When stratified by molecular subtypes, POLE and MSI-H endometrial cancers had significantly higher levels of expression of PD1/PD-L1 on peritumoral and intra-tumoral immune cells when compared to MSI stable tumors [97]. The gene discussed is CD274; the disease is endometrial cancer.